Gut microbiome predicts inflammation better than age
Your gut bacteria may say more about your health than your birth year. New research suggests that the composition of the gut microbiome is a stronger predictor of inflammation and disease risk than chronological age.
Researchers behind the study analysed stool profiles, 30 inflammatory markers in blood and 19 physiological measures in 1,199 adults aged 20 to 72. This allowed a direct comparison of how much variance age explains versus gut bacterial composition.
The results were striking. Age was associated with 40 percent of measured inflammatory markers. Gut composition, however, explained more variance than age for 97 percent of those markers. For physiological variables such as blood pressure and metabolic readings, that figure was 84 percent. People carrying the Bacteroides 2 enterotype, a distinctive cluster of gut bacteria, showed elevated pro-inflammatory markers as early as young adulthood. This resembled an inflammaging-like pattern appearing up to 37 years earlier than in people with other bacterial profiles. Their future disease risk was also higher: the researchers calculated a hazard ratio of 1.21, meaning a 21 percent higher chance of incident disease across multiple organ systems. Conversely, high bacterial diversity in the gut was linked to lower inflammation and reduced disease risk.
What is inflammaging?
These findings connect to the concept of ‘inflammaging’: a low-grade, chronic inflammatory state characteristic of biological ageing. What this research adds is that inflammaging does not appear to be purely age-driven. The composition of the gut microbiome seems to be a stronger driver, making the gut a potential target for intervention.
Not yet proof of therapeutic benefit
The study is observational: it shows an association, not causation. Whether actively improving gut composition also lowers inflammatory markers and disease risk requires further research. The results were published in Nature Communications. The researchers describe the microbiome as a ‘potentially modifiable determinant’, which is a cautious framing. Definitive therapeutic applications remain distant.
From a longevity perspective the implication is notable: if gut bacteria drive an ageing inflammatory profile, the gut deserves priority in preventive research.
Want to research this yourself?
Search for example:
- inflammaging gut microbiome
- enterotype chronic inflammation
- microbiome disease risk adults